• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性心脏病相关重度肺动脉高压患者中先前无法手术患者的肺活检结果。

Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease.

机构信息

Pediatric Cardiac Center, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, 100037 Beijing, China.

出版信息

Int J Cardiol. 2011 Aug 18;151(1):76-83. doi: 10.1016/j.ijcard.2010.04.094. Epub 2010 May 21.

DOI:10.1016/j.ijcard.2010.04.094
PMID:20494465
Abstract

BACKGROUND

Congenital heart disease with near-systemic pulmonary arterial pressures, previously thought to have irreversible pulmonary vascular disease (PVD), has been successfully corrected at our institution recently. Whether the PVD is reversible remains unknown. This study aimed to examine the nature of the pulmonary arterial vessels in these selective patients.

METHODS

All patients with congenital heart disease and severe pulmonary hypertension (PH) were selected using Diagnostic-treatment to undergo radical repair (n=49). Lung biopsy specimens were obtained during operation. The nature of PVD was determined by Heath-Edwards classification system. All specimens were quantitatively analyzed by calculating percentage media wall area, percentage media wall thickness and arteriole density.

RESULTS

Transcutaneous oxygen saturation of all selected patients increased significantly after Diagnostic-treatment (P<0.001). There were no operative deaths. Mean pulmonary artery pressure and pulmonary vascular resistance regressed significantly postoperatively (P<0.001). The incidence of postoperative PH was 59.2% (29/49). Of 49 selected patients with severe PH, 38 (77.6%) showed grade I change, 5 (10.2%) showed grade II change, 4 (8.2%) showed grade III change and only 2 (4%) showed grade IV change with plexiform lesion. The percentage media wall area, percentage media wall thickness and arteriole density were significantly increased in patients associated with PH than in normal subjects (P<0.001). Follow-up data showed the reversal of PVD in these 2 patients with plexiform lesions.

CONCLUSIONS

The PVD in these selective patients with congenital heart disease and severe PH using a Diagnostic-treatment-and-Repair strategy is generally reversible and these patients are operable in current era.

摘要

背景

先天性心脏病伴接近全身肺脉压升高,既往认为存在不可逆转的肺血管疾病(PVD),但最近我院成功对此类患者进行了根治。目前仍不清楚 PVD 是否可逆。本研究旨在检查这些选择性患者的肺动脉血管性质。

方法

采用诊断-治疗-修复策略选择所有患有先天性心脏病和严重肺动脉高压(PH)的患者(n=49)进行根治性修复。术中获取肺活检标本。采用 Heath-Edwards 分类系统确定 PVD 的性质。通过计算中膜壁面积百分比、中膜壁厚度百分比和小动脉密度对所有标本进行定量分析。

结果

所有入选患者的经皮血氧饱和度在诊断-治疗后均显著升高(P<0.001)。无手术死亡。术后平均肺动脉压和肺血管阻力明显下降(P<0.001)。术后 PH 的发生率为 59.2%(29/49)。49 例严重 PH 患者中,38 例(77.6%)表现为 I 级改变,5 例(10.2%)表现为 II 级改变,4 例(8.2%)表现为 III 级改变,仅 2 例(4%)表现为有丛样病变的 IV 级改变。与正常对照组相比,伴有 PH 的患者中膜壁面积百分比、中膜壁厚度百分比和小动脉密度明显增加(P<0.001)。随访数据显示,2 例有丛样病变的患者的 PVD 逆转。

结论

采用诊断-治疗-修复策略的先天性心脏病伴严重 PH 患者的 PVD 通常是可逆的,在当前时代这些患者是可手术的。

相似文献

1
Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease.先天性心脏病相关重度肺动脉高压患者中先前无法手术患者的肺活检结果。
Int J Cardiol. 2011 Aug 18;151(1):76-83. doi: 10.1016/j.ijcard.2010.04.094. Epub 2010 May 21.
2
[Systematic quantification of the arteries in lung biopsies of patients with congenital heart defects and its contribution to the therapeutic management].
Arq Bras Cardiol. 1997 Jan;68(1):3-8.
3
Midterm results of diagnostic treatment and repair strategy in older patients presenting with nonrestrictive ventricular septal defect and severe pulmonary artery hypertension.老年非限制性室间隔缺损合并重度肺动脉高压患者诊断性治疗及修复策略的中期结果
Chin Med J (Engl). 2014;127(5):839-44.
4
Haemodynamic correlation with lung biopsy findings in isolated ventricular septal defect with or without pulmonary hypertension.孤立性室间隔缺损伴或不伴肺动脉高压时血流动力学与肺活检结果的相关性
Hokkaido Igaku Zasshi. 1997 Nov;72(6):607-19.
5
Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect.继发孔型或静脉窦型房间隔缺损成人的高血压性肺血管疾病
Ann Thorac Surg. 2006 Jan;81(1):207-13. doi: 10.1016/j.athoracsur.2005.07.053.
6
The clinical value and risks of lung biopsy in children with congenital heart disease.先天性心脏病患儿肺活检的临床价值与风险
J Thorac Cardiovasc Surg. 1990 Mar;99(3):460-8.
7
[Clinico-histologic-morphometric correlations in pulmonary arteries among patients with heart malformations ].[心脏畸形患者肺动脉的临床-组织学-形态计量学相关性]
Pathol Res Pract. 1982;173(4):345-58.
8
Density of muscularized arteries in the lung: Its role in congenital heart disease and its clinical significance.肺中肌化动脉的密度:其在先天性心脏病中的作用及其临床意义。
Arch Pathol Lab Med. 1983 Jan;107(1):23-8.
9
Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease.先天性心脏病继发肺动脉高压可逆性中的血管重塑过程
Pathol Res Pract. 2003;199(8):521-32. doi: 10.1078/0344-0338-00457.
10
Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.雾化吸入伊洛前列素用于先天性心脏病相关长期肺动脉高压患儿的肺血管反应性测试。
Catheter Cardiovasc Interv. 2009 Jan 1;73(1):98-104. doi: 10.1002/ccd.21793.

引用本文的文献

1
The efficacy of the treat-repair-treat strategy for severe pulmonary arterial hypertension associated with congenital heart disease: a meta-analysis.治疗-修复-治疗策略治疗先天性心脏病相关重度肺动脉高压的疗效:一项荟萃分析。
BMC Cardiovasc Disord. 2023 Nov 20;23(1):569. doi: 10.1186/s12872-023-03606-z.
2
Management of systemic to pulmonary shunts and elevated pulmonary vascular resistance.体肺分流及肺血管阻力升高的管理。
ERJ Open Res. 2023 Nov 6;9(6). doi: 10.1183/23120541.00271-2023. eCollection 2023 Nov.
3
Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.
组氨酸-色氨酸-酮戊二酸溶液与圣托马斯晶体心脏停搏液的临床比较分析:来自单一机构的12年研究。
Exp Ther Med. 2017 Sep;14(3):2677-2682. doi: 10.3892/etm.2017.4814. Epub 2017 Jul 19.
4
Pushing the envelope: a treat and repair strategy for patients with advanced pulmonary hypertension associated with congenital heart disease.突破极限:一种针对先天性心脏病相关晚期肺动脉高压患者的治疗与修复策略。
Pulm Circ. 2017 Jul-Sep;7(3):747-751. doi: 10.1177/2045893217726086. Epub 2017 Sep 1.
5
Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institution.组氨酸-色氨酸-酮戊二酸溶液可降低患有与复杂先天性心脏病相关的重度肺动脉高压的高危患者的死亡率和发病率:来自单一机构的11年经验。
Braz J Med Biol Res. 2016;49(6):e5208. doi: 10.1590/1414-431X20165208. Epub 2016 May 13.
6
Epigenetics: novel mechanism of pulmonary hypertension.表观遗传学:肺动脉高压的新机制。
Lung. 2013 Dec;191(6):601-10. doi: 10.1007/s00408-013-9505-1. Epub 2013 Sep 20.